MedTrace Logo

Effects of Ping-Shuai-Gong and Arm-Swing-Exercise

NCT05343897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-04-25

No results posted yet for this study

Summary

Ping Shuai Gong (PSG) and Arm Swing Exercise (ASE) are two similar exercise with different arm-swinging strategies. This study is plan to explore the relationship between characteristics of arm-swinging movement and skin blood flow during exercise.

Conditions

  • Effects of; Movement
  • Inactivity, Physical
  • Degeneration

Interventions

BEHAVIORAL

Low intensity exercise - Ping-Shuai Gong (PSG)

Participants were asked to conduct and record 30 minutes of PSG in one day lasting for 2-month, and at least 3 days a week. A record sheet were sent to the participants in the first time, and the contact information of examiner were given as well. The examiner will check the completion of exercise execution via phone every two to three days and visit participants to confirm the correctness of movement at least one time during the 2-month intervention period.

BEHAVIORAL

Low intensity exercise - Arm-Swing Exercise (ASE)

Participants were asked to conduct and record 30 minutes of ASE in one day lasting for 2-month, and at least 3 days a week. A record sheet were sent to the participants in the first time, and the contact information of examiner were given as well. The examiner will check the completion of exercise execution via phone every two to three days and visit participants to confirm the correctness of movement at least one time during the 2-month intervention period.

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-26
Primary Completion
2021-07-03
Completion
2021-07-03

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05343897 on ClinicalTrials.gov